X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212605
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215057
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216346
https://www.thepharmaletter.com/article/shorla-oncology-gains-first-fda-approval-for-nelarabine
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216038
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216934
https://www.globenewswire.com/news-release/2021/11/26/2341466/0/en/Ocugen-Inc-Provides-an-Update-on-its-Investigational-New-Drug-Application-with-U-S-FDA-to-Initiate-a-Phase-3-Clinical-Trial-Evaluating-COVID-19-Vaccine-Candidate-COVAXIN-BBV152.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215037
https://www.eurekalert.org/pub_releases/2020-06/uok-dom062520.php#:~:text=A%20research%20team%20led%20by,most%20common%20cancer%20in%20children.
Market Place
Share 
